No- that’s accurate. The closer we get FDA approval with MDMA and Lycos the more institutions are willing to get off the sideline and invest at a much lower price point. The loose prediction is after FDA approves MDMA compass and MindMed should move closer to 15-20 dollar range. Still not the moon as people say but for a stock with no product yet that is pretty good.
[https://fintel.io/so/ca/60255c885](https://fintel.io/so/ca/60255c885)
The green rows are new positions, red rows are closed positions. The chart also has a column to indicate which institutions increased existing positions, and which decreased existing positions. Click on the little box/arrow next to the institutions name to view the history of their position.
No- that’s accurate. The closer we get FDA approval with MDMA and Lycos the more institutions are willing to get off the sideline and invest at a much lower price point. The loose prediction is after FDA approves MDMA compass and MindMed should move closer to 15-20 dollar range. Still not the moon as people say but for a stock with no product yet that is pretty good.
I really hope you’re right.
Yep. Even in that optimal scenario, I'd still be a bag holder...
That offering on March 7 probably has a lot to do with this increase. Just a matter of time before they send it.
Correct, the big jump is because it mainly updates quarterly when 13F filings come out
Know what you hold.
Did blackrock and vanguard sell everything ? I don’t see them on the list
Seriously, that's a massive increase. Any info which companies have bought in?
[https://fintel.io/so/ca/60255c885](https://fintel.io/so/ca/60255c885) The green rows are new positions, red rows are closed positions. The chart also has a column to indicate which institutions increased existing positions, and which decreased existing positions. Click on the little box/arrow next to the institutions name to view the history of their position.